An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents
Dissertations and Theses (Open Access)
Part of the Medicine and Health Sciences Commons
Skip to main content